Non-alcoholic fatty liver disease (NAFLD) affects almost one quarter of adults worldwide,
and its progressive subtype, non-alcoholic steatohepatitis can progress to advanced …

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the United
States. While the American Association for the Study of Liver Diseases guidelines define …

Introduction: Nonalcoholic fatty liver disease (NAFLD) spans steatosis through nonalcoholic
steatohepatitis (NASH), fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). NAFLD …

Nonalcoholic fatty liver disease (NAFLD) embraces histopathological entities ranging from
the relatively benign simple steatosis to the progressive form nonalcoholic steatohepatitis …

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. The
prevalence in patients with type 2 diabetes mellitus is between 55–80%. The spectrum of …

Nonalcoholic fatty liver disease (NAFLD) is entering a new era in terms of diagnosis and
conceptualization. The term NAFLD is considered to not reflect current knowledge …

Nonalcoholic fatty liver disease (NAFLD) is an accumulation of extra fat in the liver cells not
caused by alcohol consumption. This disease is an increasingly common condition and the …

Non-alcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease and
represent a common finding in highly prevalent metabolic disorders (ie type 2 diabetes …

The prevalence of nonalcoholic fatty liver disease (NAFLD), one of the most common
chronic liver diseases worldwide, has been increasing. In terms of pathological changes …

Rationale and Objectives Marked liver steatosis, steatohepatitis, and significant fibrosis are
risk factors for unfavorable outcomes in non-alcoholic fatty liver disease (NAFLD). In this …